{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:17:07Z","timestamp":1790435827578,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0032\/0002"],"award-info":[{"award-number":["RD12\/0032\/0002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM14\/00081"],"award-info":[{"award-number":["CM14\/00081"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["20141830"],"award-info":[{"award-number":["20141830"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds zur Fo\u0308rderung der wissenschaftlichen Forschung","award":["W1206 SPIN"],"award-info":[{"award-number":["W1206 SPIN"]}]},{"name":"Fonds zur Fo\u0308rderung der wissenschaftlichen Forschung","award":["W1206 SPIN"],"award-info":[{"award-number":["W1206 SPIN"]}]},{"DOI":"10.13039\/100010147","name":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda","doi-asserted-by":"crossref","award":["DN040579"],"award-info":[{"award-number":["DN040579"]}],"id":[{"id":"10.13039\/100010147","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00415-016-8147-7","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T14:58:14Z","timestamp":1462373894000},"page":"1349-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes"],"prefix":"10.1007","volume":"263","author":[{"given":"Maria","family":"Sep\u00falveda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds","family":"Armangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Martinez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Arrambide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Sola-Valls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Midaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Ari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Peschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Montalban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"issue":"7","key":"8147_CR1","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.1301296","volume":"191","author":"MC Mayer","year":"2013","unstructured":"Mayer MC, Breithaupt C, Reindl M et al (2013) Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 191(7):3594\u20133604","journal-title":"J Immunol"},{"issue":"8","key":"8147_CR2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T (2013) The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9(8):455\u2013461","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"8147_CR3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Pr\u00f6bstel","year":"2011","unstructured":"Pr\u00f6bstel AK, Dornmair K, Bittner R et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77(6):580\u2013588","journal-title":"Neurology"},{"issue":"12","key":"8147_CR4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458514566666","volume":"21","author":"IA Ketelslegers","year":"2015","unstructured":"Ketelslegers IA, Van Pelt DE, Bryde S et al (2015) Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort. Mult Scler 21(12):1513\u20131520","journal-title":"Mult Scler"},{"issue":"3","key":"8147_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71(3):276\u2013283","journal-title":"JAMA Neurol"},{"issue":"6","key":"8147_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82(6):474\u2013481","journal-title":"Neurology"},{"issue":"7","key":"8147_CR7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","volume":"21","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, Sepulveda M, Armangue T et al (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21(7):866\u2013874","journal-title":"Mult Scler"},{"issue":"6","key":"8147_CR8","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","volume":"2","author":"SM Kim","year":"2015","unstructured":"Kim SM, Woodhall MR, Kim JS et al (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2(6):e163","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8147_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311743","author":"C Lechner","year":"2015","unstructured":"Lechner C, Baumann M, Hennes EM et al (2015) Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry. doi: 10.1136\/jnnp-2015-311743","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"8147_CR10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/1352458512466317","volume":"19","author":"P Huppke","year":"2013","unstructured":"Huppke P, Rostasy K, Karenfort M et al (2013) Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 19(7):941\u2013946","journal-title":"Mult Scler"},{"issue":"3","key":"8147_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Izuka T et al (2014) Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol 75(3):411\u2013428","journal-title":"Ann Neurol"},{"issue":"2","key":"8147_CR12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","volume":"72","author":"E Martinez-Hernandez","year":"2015","unstructured":"Martinez-Hernandez E, Sepulveda M, Rost\u00e1sy K et al (2015) Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor \u03b11 subunit in patients with isolated optic neuritis. JAMA Neurol 72(2):187\u2013193","journal-title":"JAMA Neurol"},{"issue":"11","key":"8147_CR13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"11","key":"8147_CR14","doi-asserted-by":"crossref","first-page":"e79083","DOI":"10.1371\/journal.pone.0079083","volume":"8","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Sabater L, Marignier R et al (2013) An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays. PLoS One 8(11):e79083","journal-title":"PLoS One"},{"key":"8147_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2015.11.009","volume":"290","author":"L Sabater","year":"2016","unstructured":"Sabater L, Saiz A, Dalmau J, Graus F (2016) Pitfalls\u00a0in the\u00a0detection\u00a0of CV2 (CRMP5)\u00a0antibodies. J Neuroimmunol 290:80\u201383","journal-title":"J Neuroimmunol"},{"issue":"2","key":"8147_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"10","key":"8147_CR17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19(10):1261\u20131267","journal-title":"Mult Scler"},{"issue":"Pt 2","key":"8147_CR18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"D Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126(Pt 2):276\u2013284","journal-title":"Brain"},{"issue":"6","key":"8147_CR19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d. Ann Neurol 58(6):840\u2013846","journal-title":"Ann Neurol"},{"issue":"10","key":"8147_CR20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"issue":"3","key":"8147_CR21","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2(3):e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"8147_CR22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","volume":"23","author":"ED Pelt Van","year":"2016","unstructured":"Van Pelt ED, Wong YY, Ketelslegers IA et al (2016) Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol 23(3):580\u2013587","journal-title":"Eur J Neurol"},{"issue":"3","key":"8147_CR23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458515591071","volume":"22","author":"A Cobo-Calvo","year":"2016","unstructured":"Cobo-Calvo A, Sepulveda M, Bernard-Valnet R et al (2016) Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications. Mult Scler 22(3):312\u2013319","journal-title":"Mult Scler"},{"issue":"1","key":"8147_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","volume":"72","author":"EP Flanagan","year":"2015","unstructured":"Flanagan EP, Weinshenker BG, Krecke KN et al (2015) Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol 72(1):81\u201387","journal-title":"JAMA Neurol"},{"issue":"6","key":"8147_CR25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","volume":"69","author":"K Rostasy","year":"2012","unstructured":"Rostasy K, Mader S, Schanda K et al (2012) Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 69(6):752\u2013756","journal-title":"Arch Neurol"},{"issue":"9","key":"8147_CR26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","volume":"197","author":"E Bettelli","year":"2003","unstructured":"Bettelli E, Pagany M, Weiner HL et al (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197(9):1073\u20131081","journal-title":"J Exp Med"},{"issue":"4","key":"8147_CR27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","volume":"8","author":"MK Storch","year":"1998","unstructured":"Storch MK, Stefferl A, Brehm U et al (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8(4):681\u2013694","journal-title":"Brain Pathol"},{"issue":"9","key":"8147_CR28","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","volume":"116","author":"E Betteli","year":"2006","unstructured":"Betteli E, Baeten D, J\u00e4ger A et al (2006) Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116(9):2393\u20132402","journal-title":"J Clin Invest"},{"issue":"5","key":"8147_CR29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5414\/NP300545","volume":"31","author":"R H\u00f6ftberger","year":"2012","unstructured":"H\u00f6ftberger R, Dalmau J, Graus F (2012) Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol 31(5):337\u2013341","journal-title":"Clin Neuropathol"},{"key":"8147_CR30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.38.2.180","volume":"38","author":"DW Paty","year":"1988","unstructured":"Paty DW, Oger JF, Kastrukoff LF et al. (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180\u2013185","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8147-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8147-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8147-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:23:02Z","timestamp":1559056982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8147-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["8147"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8147-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]}}}